相关实验视频
Updated: Jan 13, 2026

07:09
Isolation of Adipose Tissue Immune Cells
Published on: May 22, 2013
37.0K
肥胖中的细胞免疫:病理生理学见解和腹手术的影响
Tania Rivera-Carranza1,2, Angélica León-Téllez-Girón3,4, Raquel González-Vázquez5
1Colegio de Ciencias y Humanidades, Academia de Nutricion y Salud, Universidad Autonoma de la Ciudad de Mexico, Plantel Casa Libertad, Mexico City 09620, Mexico.
International journal of molecular sciences
|October 29, 2025
概括
肥胖会导致慢性炎症,影响健康. 这篇综述探讨了免疫细胞,特别是淋巴细胞亚群是如何驱动这种炎症的,以及减肥手术如何帮助管理它.
科学领域:
- 免疫学 免疫学 免疫学
- 代谢障碍 代谢障碍 代谢障碍
- 细胞生物学 细胞生物学
背景情况:
- 肥胖症的特点是慢性低度炎症.
- 细胞免疫是与肥胖相关的炎症和相关的慢性疾病的组成部分.
- 与正常体重个体相比,肥胖患者的免疫代谢变化是不同的.
研究的目的:
- 审查肥胖相关炎症中淋巴细胞群的分子和病理生理机制.
- 探索减肥手术在通过免疫细胞调节来控制肥胖引起的炎症中的作用.
主要方法:
- 现有文献的叙述性审查.
- 对肥胖症中的免疫代谢概况和淋巴细胞亚群的分析.
- 检查分子过程,如蛋白质修饰和信号转导通路.
主要成果:
- 肥胖会导致显著的免疫代谢变化.
- 淋巴细胞亚种群在肥胖中协调关键的炎症过程.
- 减肥手术导致免疫细胞比例的变化.
结论:
- 了解淋巴细胞在肥胖炎症中的作用是评估疾病严重程度和风险的关键.
- 向淋巴细胞亚种群为与肥胖有关的炎症提供了潜在的治疗策略.
- 腹部外科手术在治疗肥胖引起的炎症方面表现有前途.
相关概念视频
Pharmacokinetics in Obese Patients: Drug Absorption and Distribution
235
Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...
235
Obesity
1.1K
The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in...
1.1K
Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion
165
Drug metabolism, a critical process in the liver, involves two primary phases: Phase I reactions and Phase II conjugation. Obesity introduces significant alterations in this metabolic process, primarily due to fatty infiltration of the liver, leading to conditions such as nonalcoholic fatty liver disease (NAFLD). This condition can modify the activities of both Phase I and II enzymes, impacting how drugs are metabolized in obese patients.Phase I metabolism sees variable effects across...
165
Psychoneuroimmunology: Diabetes and Cancer
432
Chronic stress has been linked to both the onset and progression of serious health conditions, including Type 2 diabetes and cancer. Type 2 diabetes, a widespread chronic illness, is closely associated with obesity and insulin resistance, both of which often worsen under stress. Studies indicate that men experiencing high levels of chronic stress face a 45% higher risk of developing diabetes compared to those with minimal stress. Stress triggers physiological responses that elevate blood...
432
Drug Dosing: Obese Patients
217
In the United States, obesity is a prominent concern. It is linked to heightened mortality rates due to increased occurrences of conditions such as hypertension, atherosclerosis, coronary artery disease, and diabetes compared to nonobese individuals. A patient is classified as obese if their actual body weight surpasses the ideal or desirable body weight by 20%, based on Metropolitan Life Insurance Company data. Ideal body weights consider average weights and heights for males and females...
217
Cell-mediated Immune Responses
83.4K
Overview
83.4K

